富血小板血浆对足底筋膜炎疼痛的积极效果:双盲多中心随机对照试验
该双盲多中心随机对照试验将115例慢性足底筋膜炎患者分配至富血小板血浆(PRP)组或皮质类固醇注射组,主要结局为足功能指数(FFI)疼痛评分。结果显示,调整基线差异后,PRP组在1年随访时疼痛评分显著低于对照组(均差14.4;95%CI 3.2-25.6),且PRP组FFI残疾评分也显著低于对照组(均差12.0;95%CI 2.3-21.6)。结论认为PRP似乎比皮质类固醇注射更能减轻疼痛并改善功能。
要点
- PRP组1年时FFI疼痛评分显著低于皮质类固醇组(均差14.4;95%CI 3.2-25.6)。
- PRP组FFI残疾评分显著低于对照组(均差12.0;95%CI 2.3-21.6)。
核心结论
- 对慢性足底筋膜炎患者,PRP治疗似乎比皮质类固醇注射更能减轻疼痛并改善功能。
研究设计与样本
- 双盲多中心随机对照试验,证据等级1级;115例慢性足底筋膜炎患者随机分配至PRP组(63例)或皮质类固醇注射组(52例)。
主要发现
- 对照组FFI疼痛评分快速下降后随访期间保持稳定;PRP组疼痛减轻较温和但12个月时达到比对照组更低的点。
- 调整基线差异后,PRP组1年随访时疼痛评分显著低于对照组(均差14.4;95%CI 3.2-25.6)。
- PRP组FFI残疾评分显著低于对照组(均差12.0;95%CI 2.3-21.6)。
关键数值与推荐
- 主要结局为FFI疼痛评分;次要结局包括FFI活动、FFI残疾、美国足踝骨科协会评分及WHOQOL-BREF生活质量。
- 结局在基线及术后4、12、26周和1年时测量。
临床怎么用
- 对于慢性足底筋膜炎,PRP注射可作为皮质类固醇注射之外的治疗选择,1年随访时疼痛和功能结局似乎更优。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When nonoperative treatment for chronic plantar fasciitis fails, often a corticosteroid injection is given. Corticosteroid injection gives temporary pain reduction but no healing. Platelet-rich plasma (PRP) has proven to be a safe therapeutic option in the treatment of tendon, muscle, bone, and cartilage injuries. PURPOSE: To determine the effectiveness of PRP as compared with corticosteroid injections for chronic plantar fasciitis. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: Patients with chronic plantar fasciitis were allocated to have steroid injection or PRP. The primary outcome measure was the Foot Function Index (FFI) Pain score. Secondary outcome measures were function, as scored by the FFI Activity, FFI Disability, and American Orthopaedic Foot & Ankle Society, and quality of life, as scored with the short version of the World Health Organization Quality of Life (WHOQOL-BREF). All outcomes were measured at baseline and at 4, 12, and 26 weeks and 1 year after the procedure. RESULTS: Of the 115 patients, 63 were allocated to the PRP group, of which 46 (73%) completed the study, and 52 were allocated to the control group (corticosteroid injection), of which 36 (69%) completed the study. In the control group, FFI Pain scores decreased quickly and then remained stable during follow-up. In the PRP group, FFI Pain reduction was more modest but reached a lower point after 12 months than the control group. After adjusting for baseline differences, the PRP group showed significantly lower pain scores at the 1-year follow-up than the control group (mean difference, 14.4; 95% CI, 3.2-25.6). The number of patients with at least 25% improvement (FFI Pain score) between baseline and 12-month follow-up differed significantly between the groups. Of the 46 patients in the PRP group, 39 (84.4%) improved at least 25%, while only 20 (55.6%) of the 36 in the control group showed such an improvement (P = .003). The PRP group showed significantly lower FFI Disability scores than the control group (mean difference, 12.0; 95% CI, 2.3-21.6). CONCLUSION: Treatment of patients with chronic plantar fasciitis with PRP seems to reduce pain and increase function more as compared with the effect of corticosteroid injection. REGISTRATION: NCT00758641 (ClinicalTrials.gov identifier).
引用
- Peerbooms JC, Lodder P, den Oudsten BL, et al. Positive Effect of Platelet-Rich Plasma on Pain in Plantar Fasciitis: A Double-Blind Multicenter Randomized Controlled Trial. Am J Sports Med. 2019. PMID: 31603721. doi:10.1177/0363546519877181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。